Michael Goldberg
Pain Medicine · Indianapolis, INNPI 1598293409
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 62.3% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $8,001, 6.4 times the $1,257 reported in 2021.
Across 116 payments — averaging $110.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Medtronic$3K
- Boston Scientific$1K
- Saluda Medical Americas, Inc.$401
- Globus Medical$279
- SPR Therapeutics, Inc$268
- plus $230 from 7 others
What the payments were for
- Speaking & faculty fees$4,40034%
- Travel & lodging$5,12640%
- Food & beverage$3,24025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 48 | $7,956 |
| Medtronic | 32 | $2,568 |
| Boston Scientific | 10 | $1,064 |
| Saluda Medical Americas, Inc. | 4 | $401 |
| Globus Medical | 7 | $279 |
| SPR Therapeutics, Inc | 6 | $268 |
| Vertos Medical, Inc. | 2 | $72 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Nevro Corp. | 1 | $28 |
| Vertex | 1 | $27 |
| Si-bone, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Stryker | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$7,064
- INTELLIS ADAPTIVESTIM$857
- KYPHON EXPRESS II KYPHOPAK TRAY$832
- SPECTRA WAVEWRITER$612
- Evoke$341
- SPRINT PNS System$238
- Vanta$172
- Senza$134
- INCEPTIV$119
How this compares
$12,766 in reported general payments places this provider in the 80th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 254 | $2,878 |
| Pregabalin | 87 | $1,874 |
| Naproxen | 53 | $592 |
| Celecoxib | 36 | $425 |
| Cyclobenzaprine Hcl | 67 | $371 |
| Diclofenac Sodium | 37 | $308 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $267 |
| Nabumetone | 22 | $211 |
| Baclofen | 13 | $199 |
| Oxycodone Hcl | 16 | $196 |
| Tizanidine Hcl | 38 | $172 |
| Meloxicam | 62 | $138 |
| Methylprednisolone | 18 | $122 |
| Cephalexin | 23 | $70 |
| Duloxetine Hcl | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Indianapolis
- John SwoffordIndianapolis$127K
- Philip ShumskyIndianapolis$27K
- Thelma Green MackIndianapolis$11K
- Troy PfefferkornIndianapolis$8K
- Lori KieferIndianapolis$5K
- Raheleh Rahimi DarabadIndianapolis$5K
- Ting WeiIndianapolis$5K
- Ahmed ElsahyIndianapolis$5K
- John KihlkenIndianapolis$4K
- Derron WilsonCarmel$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.